Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
264
datasets available to search
ShareScore release 0.9.0
Dataset results
264 results for “virology”
Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)
ClinicalTrials.gov study NCT05312918. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa
ClinicalTrials.gov study NCT05373758. IPD Sharing: Not stated. Countries: 2. Publications: 0.
PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)
ClinicalTrials.gov study NCT01056172. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH)
ClinicalTrials.gov study NCT06967753. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection
ClinicalTrials.gov study NCT03449706. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine a
ClinicalTrials.gov study NCT05222945. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial
ClinicalTrials.gov study NCT00643968. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen
ClinicalTrials.gov study NCT01714414. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1
ClinicalTrials.gov study NCT03502005. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
ClinicalTrials.gov study NCT05220358. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed
ClinicalTrials.gov study NCT06544733. IPD Sharing: NO. Countries: 2. Publications: 0.
Darunavir/Cobicistat and Dolutegravir to Maintain Virologic Suppression and Reduce NRTI-associated Toxicity
ClinicalTrials.gov study NCT02499978. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy
ClinicalTrials.gov study NCT02611895. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients
ClinicalTrials.gov study NCT00356616. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) Infection
ClinicalTrials.gov study NCT02391805. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Impact of M184V on the Virological Efficacy to 3TC/DTG (LAMRES)
ClinicalTrials.gov study NCT04568239. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition
ClinicalTrials.gov study NCT04573634. IPD Sharing: NO. Countries: 1. Publications: 0.
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening
ClinicalTrials.gov study NCT02833298. IPD Sharing: NO. Countries: 1. Publications: 0.
Virologic Treatment Failure and Drug Resistance in HIV-infected Kenyan Children (RESPECT)
ClinicalTrials.gov study NCT03120065. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Compare the Virologic Efficacy in Cerebrospinal Fluid (CSF) and Neurocognitive State in Patients Infected by HIV-1 Long-term Treatment (> 3 Years) With Lopinavir / Ritonavir Monotherapy
ClinicalTrials.gov study NCT01116817. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.